Forskning
Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital
Udgivet

Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Oral and anal carriage of Streptococcus pneumoniae among sexually active men with HIV who have sex with men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Kamille Fogh
  • Jarl E Strange
  • Bibi F S S Scharff
  • Alexandra R R Eriksen
  • Rasmus B Hasselbalch
  • Henning Bundgaard
  • Susanne D Nielsen
  • Charlotte S Jørgensen
  • Christian Erikstrup
  • Jakob Norsk
  • Pernille Brok Nielsen
  • Jonas H Kristensen
  • Lars Østergaard
  • Svend Ellermann-Eriksen
  • Berit Andersen
  • Henrik Nielsen
  • Isik S Johansen
  • Lothar Wiese
  • Lone Simonsen
  • Thea K Fischer
  • Fredrik Folke
  • Freddy Lippert
  • Sisse R Ostrowski
  • Thomas Benfield
  • Kåre Mølbak
  • Steen Ethelberg
  • Anders Koch
  • Ute Wolff Sönksen
  • Anne-Marie Vangsted
  • Tyra Grove Krause
  • Anders Fomsgaard
  • Henrik Ullum
  • Robert Skov
  • Kasper Iversen
Vis graf over relationer

"Testing Denmark" is a national, large-scale, epidemiological surveillance study of SARS-CoV-2 in the Danish population. Between September and October 2020, approximately 1.3 million people (age >15 years) were randomly invited to fill in an electronic questionnaire covering COVID-19 exposures and symptoms. The prevalence of SARS-CoV-2 antibodies was determined by point-of care rapid test (POCT) distributed to participants' home addresses. In total, 318,552 participants (24.5% invitees) completed the study and 2,519 (0.79%) were seropositive. Of the participants with a prior positive PCR test (n = 1,828), 29.1% were seropositive in the POCT. Although seropositivity increased with age, participants 61 years and over reported fewer symptoms and were tested less frequently. Seropositivity was associated with physical contact with SARS-CoV-2 infected individuals (risk ratio [RR] 7.43, 95% CI: 6.57-8.41), particular in household members (RR 17.70, 95% CI: 15.60-20.10). A greater risk of seropositivity was seen in home care workers (RR 2.09, 95% CI: 1.58-2.78) compared to office workers. A high degree of adherence with national preventive recommendations was reported (e.g., >80% use of face masks), but no difference were found between seropositive and seronegative participants. The seroprevalence result was somewhat hampered by a lower-than-expected performance of the POCT. This is likely due to a low sensitivity of the POCT or problems reading the test results, and the main findings therefore relate to risk associations. More emphasis should be placed on age, occupation, and exposure in local communities. IMPORTANCE To date, including 318,522 participants, this is the largest population-based study with broad national participation where tests and questionnaires have been sent to participants' homes. We found that more emphasis from national and local authorities toward the risk of infection should be placed on age of tested individuals, type of occupation, as well as exposure in local communities and households. To meet the challenge that broad nationwide information can be difficult to gather. This study design sets the stage for a novel way of conducting studies. Additionally, this study design can be used as a supplementary model in future general test strategy for ongoing monitoring of COVID-19 immunity in the population, both from past infection and from vaccination against SARS-CoV-2, however, with attention to the complexity of performing and reading the POCT at home.

OriginalsprogEngelsk
Artikelnummere01330
TidsskriftMicrobiology spectrum
Vol/bind9
Udgave nummer3
Sider (fra-til)1-12
Antal sider12
ISSN2165-0497
DOI
StatusUdgivet - 22 dec. 2021

ID: 69835697